XBiotech Inc. has announced that Sushma Shivaswamy, currently Chief Scientific Officer, will serve as interim CEO effective December 8, 2025. During her tenure as interim CEO and Chief Scientific Officer, her annual base salary will be increased to $750,000. The company stated that her bonus structure and full remuneration package will be determined by the Compensation Committee at a later date. Additionally, retiring CEO John Simard will receive compensation for his new consulting role as specified in his Executive Employment Agreement, and XBiotech intends to pay him the severance amount outlined in that agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XBiotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-007836), on December 09, 2025, and is solely responsible for the information contained therein.